Safety and efficacy of an extended-release peptide YY analogue for obesity: A randomized, placebo-controlled, phase 1 trial.
Tricia Mei-Mei TanJames MinnionBernard KhooLaura-Jayne BallReshma MalviyaEmily DayFrancesca FiorentinoCharlie BrindleyJim BushStephen R BloomPublished in: Diabetes, obesity & metabolism (2021)
Our results support the continued development of Y14 as a novel treatment for obesity.